Medical Association Of Georgia Strongly Opposes Expansion Of State’s ”Medicinal Cannabis” Law

The House of Delegates of the Medical Association of Georgia (MAG) passed a strongly worded resolution opposing the expansion of “medical” marijuana at its annual meeting October 20-21. Passed unanimously, the resolution sends a clear signal to legislators to reject a Georgia House of Representatives resolution introduced in the 2017 session that carries over to next year. That resolution, if passed, would enable legislators to place a constitutional amendment on the state’s November 2018 ballot to cultivate, process, and sell marijuana for medical use throughout the state.

The issue has evolved in each legislative session since 2014. Current law allows people with 14 different conditions to apply to the Georgia Department of Public Health for a card that provides legal immunity for possessing 20 fluid ounces of “medicinal cannabis” that can contain 5 percent THC.
The MAG House of Delegates’ resolution notes that “calling marijuana ‘medical cannabis’ or ‘low THC oil’ does not alter its psychoactive, neurotoxic, and addictive effects. Marijuana at THC levels of 3 percent, 4 percent, or 5 percent has resulted in hundreds of thousands of Americans experiencing cannabis use dependence since the 1980s.”
It points out that “THC has been contraindicated for use in treatment of conditions of children in studies by Children’s Hospital Colorado, Boston Children’s Hospital, Harvard Medical School and Duke University.” It adds that marijuana-related fatal road crashes have increased in Colorado and Washington since those two states fully legalized the drug.
The resolution begins by stating, “Legislators or voters should not decide what medical conditions should be treated by a non-standardized, un-tested drug, namely artisanal THC Oil and related marijuana products, and then base treatment on non-scientific anecdotal information.”
For these and other reasons, the resolution:
“RESOLVED, that the Medical Association of Georgia oppose the expansion of the legalization of non-standard and non-FDA approved use of cannabis for medical use in Georgia and educate physicians and other clinicians on the risks of artisanal cannabis products lacking FDA approval.”
And “RESOLVED, that the Georgia Delegation submit a resolution to the American Medical Association to work with the National Institutes of Health to ease some of the barriers to medical research regarding chemical components of marijuana such as cannabidiol that show great promise.”
The House of Delegates is MAG’s primary legislative and policy-making body, according to its website. It consists of county and specialty medical societies. Dr. Craig Kerins of the Richmond County Medical society introduced the resolution, which was written by Susan Blank, MD, president of the Georgia Society of Addiction Medicine and Gregg Raduka, PhD, executive director of Let’s Be Clear Georgia.
Read full text here.

Source: Email from National Families in Action November 2017


Back to top of page

Powered by WordPress